abstract |
The present invention relates to antisense oligonucleotides that modulate the expression and/or function of sirtuins (SIRTs), particularly by targeting natural antisense polynucleotides to sirtuins (SIRTs). The present invention also relates to the identification of these antisense oligonucleotides and their use in the treatment of diseases and disorders associated with sirtuin (SIRT) expression. |